Safety and efficacy assessment of Product on ski
- Registration Number
- CTRI/2023/03/050222
- Lead Sponsor
- BRIGHT LIFECARE PVT. LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 33
1.Indian female subjects.
2.Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup)
3.Between 35 and 55 years of age.
4.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)
1.Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
2.Having refused to give her/his assent by signing the consent form
3.Taking part in another study liable to interfere with this study
4.Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months)
5.Being asthmatic.
6. Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex
7.Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
8.Having cutaneous hypersensitivity.
9.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
10.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
11.Having changed his/her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit.
12.Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted)
13.Refusing to follow the restrictions below during the study:
- Do not take part in any family planning activities leading to pregnancy and breastfeeding
- Do not take part in another study liable to interfere with this study
- Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
- Do not change his/her cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit.
- Do not practice water activities (swimming pool, sauna, hammam, balneotherapy)
- During the study: Do not use other cosmetic products than the tested products to the studied areas. Do not use hair oil
- The day of the measurements : No other cosmetic products must be used (only face cleaned with water is accepted)
14.Having started, changed or stopped a Hormone Replacement Therapy in the past 6 months.
15.Having started, changed or stopped her tobacco consumption (for smokers consuming more than 10 cigarettes per day) in the previous 6 months.
16. Having taken a Dehydroepiandrosterone based treatment in the previous 6 months.
17.Having applied products with an anti-wrinkle action particularly firming products (Retinoic acid, retinol, retinaldehyde, Alpha Hydroxy Acid….) in the 2 weeks preceding the start of the study.
18.Having made injections of anti-wrinkle products (collagen, hyaluronic acid, botulinic toxin…) in the previous 12 months.
19. Having undergone techniques with aesthetic aim (chemical peel, mechanical dermabrasion, laser, pulsed flash lamp …) in the previous year.
20. Having undergone surgery of the skin-muscular slackening on the face (lifting) in the previous 5 years.
21.Taking oral supplements with major or minor effect on whitening of skin (e.g. vitamin C, beta-carotene…)
22. Having applied products with a depigmenting action (hydroquinone or derivates…) in the 4 weeks preceding the start of
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in fine lines and wrinkles, reduction in density of dark spots (age spots), improvement in skin moisturization, improvement in skin brightening and improvement in skin firmnessTimepoint: Baseline, 28 days, 56 days & 84 days
- Secondary Outcome Measures
Name Time Method ilTimepoint: Not applicable